New guidelines prepare for eventual item-level serialization, while embodying FDA guidance for barcoded hospital-supply products
Although the very concept of standardization of something like National Drug Codes (NDCs) on pharmaceutical packages would seem to be straightforward, in fact there have been many variations—with special placeholder digits in the NDC, for example—that various parts of the industry have adopted. For that reason, as well as to incorporate new standards definitions from the GS1 organization, HDMA has updated its Guidelines for Bar Coding in the Pharmaceutical Supply Chain, and has published a comprehensive book on the topic available for sale at its website.
The Guidelines, last revised in 2005, generally do not require some fullscale revision of current barcoding practices. But they do acknowledge the new emphasis on 2D Datamatrix codes (along with various linear codes), and the Standardized Numerical Identifier (SNI) that FDA came out with in March 2010. Combine the SNI with a unique alphanumeric string, and you wind up with the serialized NDC (sNDC) that FDA believes could become part of a full track-and-trace electronic pedigree system.
Upwards of 16 specific recommendations by HDMA are being made the Guidelines publication, ranging from replacing line scanners with imaging scanners (which can handle both linear barcodes and 2D codes), label placement, and GS1 code formatting instructions, among others. The Guidelines also say that thermal transfer is the best type of barcode printing (which might be news to vendors of laser and other marking techniques).
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.